Financial News

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH)

By: Newsfile

Dallas, Texas--(Newsfile Corp. - September 30, 2022) - Bio-Path Holdings, Inc. (Nasdaq: BPTH): The full report can be accessed by clicking on the following link:

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Bio-Path's pipeline continues to expand with new cancer indications
  • Bio-Pathhas completed Phase 1 clinical trials for its lead candidate prexigebersen for AML and other blood cancers
  • The Company most recently reported that cash on hand as of 6/30/22 is sufficient to fund operations according to plan for at the next 12 months

Cannot view this image? Visit:

Click image above to view full announcement.

About Stonegate Capital Partners
Stonegate Capital Partners is a Dallas-based corporate advisory firm dedicated to serving the specialized needs of small-cap public companies. Since our inception, our mission has been to find innovative, undervalued public companies for our network of leading institutional investors who seek high-quality investment opportunities.


Stonegate Capital Partners
(214) 987-4121

Source: Stonegate, Inc.

To view the source version of this press release, please visit

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info